Cargando…
A cohort study of medication adherence among patients with chronic obstructive pulmonary disease in Egypt
Chronic obstructive pulmonary disease (COPD), the most common chronic respiratory disease, is expected to become the third leading cause of death worldwide in 2020. A prospective cohort study conducted in 2017 and 2018 aimed to identify factors associated with inhaler treatment adherence in patients...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360753/ https://www.ncbi.nlm.nih.gov/pubmed/32665684 http://dx.doi.org/10.1038/s41533-020-0188-9 |
_version_ | 1783559272822472704 |
---|---|
author | Joël Ladner El Badrawy, Mahinour Nofal, Anas Saba, Joseph Audureau, Etienne |
author_facet | Joël Ladner El Badrawy, Mahinour Nofal, Anas Saba, Joseph Audureau, Etienne |
author_sort | Joël Ladner |
collection | PubMed |
description | Chronic obstructive pulmonary disease (COPD), the most common chronic respiratory disease, is expected to become the third leading cause of death worldwide in 2020. A prospective cohort study conducted in 2017 and 2018 aimed to identify factors associated with inhaler treatment adherence in patients with COPD in Cairo (Egypt). Physicians collected data regarding patient deaths, treatment-related adverse events, and patients’ social support (no support, patient, support by spouse, children, and siblings) from their patients with COPD. The reason for treatment discontinuation was categorized as per patient decision or per physician decision. Adherence was categorized as treatment continued or treatment stopped. Patients who decided to stop treatment were considered non-adherent to COPD therapy. A total of 1311 patients as well as 98 physicians and 205 pharmacists were included. Pharmacists and social support (spouse, children/siblings) were identified as key positive factors in patients’ decisions to adhere to their prescribed COPD treatment regimens. A total of 631 patients (48.1%) stopped the treatment, including 170 (27.0%) due to patient decision and 55 (8.7%) deceased. After Cox model analysis, a low number of patients (6–19) attended by the pharmacist was a significant predictive factor (hazard ratio [HR] = 1.40, 95% confidence interval [CI] = 1.03–1.91, p = 0.03) for deciding to stop treatment. A wife or husband (HR = 0.85, 95% CI = 0.72–1.02, p = 0.07) as well as children or brother/sister (HR = 0.77, 95% CI = 0.57–1.04, p = 0.08) provided a positive effect for continued treatment. Pharmacists are well positioned to play a role as an essential public health resource that can help improve adherence as well as social support that should be considered as an important component to improve adherence to long-term therapy in COPD as well as other chronic non-communicable diseases in low- and middle-income countries. |
format | Online Article Text |
id | pubmed-7360753 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-73607532020-07-20 A cohort study of medication adherence among patients with chronic obstructive pulmonary disease in Egypt Joël Ladner El Badrawy, Mahinour Nofal, Anas Saba, Joseph Audureau, Etienne NPJ Prim Care Respir Med Article Chronic obstructive pulmonary disease (COPD), the most common chronic respiratory disease, is expected to become the third leading cause of death worldwide in 2020. A prospective cohort study conducted in 2017 and 2018 aimed to identify factors associated with inhaler treatment adherence in patients with COPD in Cairo (Egypt). Physicians collected data regarding patient deaths, treatment-related adverse events, and patients’ social support (no support, patient, support by spouse, children, and siblings) from their patients with COPD. The reason for treatment discontinuation was categorized as per patient decision or per physician decision. Adherence was categorized as treatment continued or treatment stopped. Patients who decided to stop treatment were considered non-adherent to COPD therapy. A total of 1311 patients as well as 98 physicians and 205 pharmacists were included. Pharmacists and social support (spouse, children/siblings) were identified as key positive factors in patients’ decisions to adhere to their prescribed COPD treatment regimens. A total of 631 patients (48.1%) stopped the treatment, including 170 (27.0%) due to patient decision and 55 (8.7%) deceased. After Cox model analysis, a low number of patients (6–19) attended by the pharmacist was a significant predictive factor (hazard ratio [HR] = 1.40, 95% confidence interval [CI] = 1.03–1.91, p = 0.03) for deciding to stop treatment. A wife or husband (HR = 0.85, 95% CI = 0.72–1.02, p = 0.07) as well as children or brother/sister (HR = 0.77, 95% CI = 0.57–1.04, p = 0.08) provided a positive effect for continued treatment. Pharmacists are well positioned to play a role as an essential public health resource that can help improve adherence as well as social support that should be considered as an important component to improve adherence to long-term therapy in COPD as well as other chronic non-communicable diseases in low- and middle-income countries. Nature Publishing Group UK 2020-07-14 /pmc/articles/PMC7360753/ /pubmed/32665684 http://dx.doi.org/10.1038/s41533-020-0188-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Joël Ladner El Badrawy, Mahinour Nofal, Anas Saba, Joseph Audureau, Etienne A cohort study of medication adherence among patients with chronic obstructive pulmonary disease in Egypt |
title | A cohort study of medication adherence among patients with chronic obstructive pulmonary disease in Egypt |
title_full | A cohort study of medication adherence among patients with chronic obstructive pulmonary disease in Egypt |
title_fullStr | A cohort study of medication adherence among patients with chronic obstructive pulmonary disease in Egypt |
title_full_unstemmed | A cohort study of medication adherence among patients with chronic obstructive pulmonary disease in Egypt |
title_short | A cohort study of medication adherence among patients with chronic obstructive pulmonary disease in Egypt |
title_sort | cohort study of medication adherence among patients with chronic obstructive pulmonary disease in egypt |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360753/ https://www.ncbi.nlm.nih.gov/pubmed/32665684 http://dx.doi.org/10.1038/s41533-020-0188-9 |
work_keys_str_mv | AT joelladner acohortstudyofmedicationadherenceamongpatientswithchronicobstructivepulmonarydiseaseinegypt AT elbadrawymahinour acohortstudyofmedicationadherenceamongpatientswithchronicobstructivepulmonarydiseaseinegypt AT nofalanas acohortstudyofmedicationadherenceamongpatientswithchronicobstructivepulmonarydiseaseinegypt AT sabajoseph acohortstudyofmedicationadherenceamongpatientswithchronicobstructivepulmonarydiseaseinegypt AT audureauetienne acohortstudyofmedicationadherenceamongpatientswithchronicobstructivepulmonarydiseaseinegypt AT joelladner cohortstudyofmedicationadherenceamongpatientswithchronicobstructivepulmonarydiseaseinegypt AT elbadrawymahinour cohortstudyofmedicationadherenceamongpatientswithchronicobstructivepulmonarydiseaseinegypt AT nofalanas cohortstudyofmedicationadherenceamongpatientswithchronicobstructivepulmonarydiseaseinegypt AT sabajoseph cohortstudyofmedicationadherenceamongpatientswithchronicobstructivepulmonarydiseaseinegypt AT audureauetienne cohortstudyofmedicationadherenceamongpatientswithchronicobstructivepulmonarydiseaseinegypt |